AVAC is excited to launch From the Lab to the Jab, a series of advocates’ guides that highlight key advocacy issues to ensure equitable access to safe, effective and affordable vaccines.
Co-created as part of our USAID-supported Coalition to Accelerate and Support Prevention Research (CASPR), with additional support from the New Venture Fund, From the Lab to the Jab issue briefs provide a roadmap for advocacy to advance the development of essential vaccines for HIV, COVID-19, tuberculosis, and other global public health threats, and approaches to ensure equitable access to these life-saving vaccines. Additional topics cover the research and development (R&D) process, the role of mRNA technology; and the need for local vaccine production.
From the Lab to the Jab: Vaccine Research and Development
Providing a roadmap for advocacy to advance the development of essential vaccines for HIV, COVID-19, tuberculosis and other global public health threats.
A Look at mRNA Technology: What is it and What it Means for Global Health Equity
Looking at what mRNA is, how it works, current knowledge gaps and ideas for advocacy to harness its potential.
From the Lab to the Jab: Local Vaccine Production
This issue looks at the current state of local production, what is needed to facilitate it, and ideas for advocacy to harness its potential.
From the Lab to the Jab: Vaccine Access – What’s Working and What’s Next
Examining the web of issues influencing access to vaccines.
Stay tuned for the From the Lab to the Jab Webinar in January 2024, and be part of the conversation that will use these briefs to strengthen advocacy and create a roadmap to achieve key transformational priorities in global health. Watch this space for additional details or sign up to receive emails from AVAC.